Globus Medical stock is down today on an unexpectedly soft Q1 amid an earlier-than-planned integration with recently acquired ...

Solventum, spun off from 3M in April 2024, reported $2.1 billion in sales for the first quarter of 2025, an increase of 2.6%.

The Andover, Massachusetts–based medtech company, which offers an organ care system (OCS) for transplant therapy, hit $143.5 ...

SS Innovations plans to submit a de novo classification request to the U.S. FDA for its SSi Mantra 3 surgical robotic system.

Bausch + Lomb announced today that it received CE mark approval for its LuxLife full range of vision intraocular lens (IOL).

GE HealthCare (Nasdaq: GEHC) announced today that it received FDA 510(k) clearance for its Aurora nuclear medicine system and ...

Boston Scientific (NYSE: BSX) + Boston Scientific Corp. $104.068 0.15% Open 104.222 Day High 104.79 52 Week High 79.43 52 ...

Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system.

BrightHeart has its second FDA clearance for updates to its platform, an AI-powered digital screening tool for congenital ...

Masimo (Nasdaq: MASI) shares fell after hours today on first-quarter results that beat the consensus forecast.

Johnson & Johnson MedTech, Stryker and Zimmer Biomet lead MassDevice's annual list of the world's largest orthopedic device ...

FastWave Medical announced today that it received Institutional Review Board (IRB) approval to begin a coronary feasibility ...